Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Identify which tilts (such as value or quality) tend to be more tax-efficient in retirement index funds and how these choices affect after-tax performance and risk.
24,606 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Two clean-energy stock contenders—EOS and Plug Power—promise very different routes to a low-carbon future. This deep ...
Netflix faced a sharp move lower as investors weighed subscriber growth, content costs, and tougher competition. This...
A pivotal hearing in New York tests the CLARITY Act as Congress debates crypto rules. BTC, ETH and XRP face a regulat...
A Seattle federal judge has ordered arbitration in the consolidated RESPA case against Zillow, pausing the lawsuit wh...
Carnival beat on the bottom line and top line, but the stock sank on the day. Analysts point to a price prediction: c...
In the stock market today, june, chips rally on AI demand while big tech retreats on pricing. This deep dive breaks d...
Bitcoin found itself at a fresh test of a long standing benchmark after slipping below a key line used by traders to ...
Micron stock just dropped as traders weigh demand for memory parts against a backdrop of cyclical pricing. This artic...
Sezzle continues to gain traction in a competitive BNPL market. This article examines why sezzle still looks attracti...
Cardano ADA is trading within a tight range as traders weigh the ghost chain label and upcoming ecosystem development...
Microsoft leads a renewed sector rotation as AI momentum and stable cloud revenue lift its outlook, while Intel stumb...